AKAN

Conviction 62HealthcareScan · Thu, Jun 25, 2026

AKAN$14.55-9.12%

ResistanceSupportVol 14

Vol MA14 440.48K

Mar 26Apr 14May 1May 19Jun 8Jun 25

AKANDA CORP.Drug Manufacturers - Specialty & Genericwww.akandacorp.com ↗

Price14.55

Change-9.12%

Gap-5.00%

Rel volume0.14×

Avg volume334.02K

Avg $ vol6.14M

SMA 2016.92

SMA 5019.51

SMA 2006.00

Price vs 50-25.42%

Price vs 200+142.66%

MA stackmixed

50/200 cross—

Supertrenddown · 24.26

RSI (14)44

MACD hist-0.18

MACD crossbear · 3d

Stoch %K / %D17 / 25

ADX (14)23

+DI / −DI30 / 21

RSI divergence—

MACD divergence—

ATR %+24.91%

ADR %13.31%

52w high57.09

52w low0.4500

From 52w high-74.51%

Above 52w low+3133.33%

New 52w highNo

SqueezeOn · 3d

Bollinger width53.99%

%B0.24

Donchian pos16.52%

Donchian high25.01

Donchian low12.48

AVWAP (52w high)34.92

vs AVWAP high-58.33%

AVWAP (52w low)14.36

vs AVWAP low+1.29%

OBV trendUp

Chaikin MF (20)-0.43

Today vs 20d0.14×

Avg vol (14d)440.48K

Avg vol (20d)334.02K

Avg $ vol (20d)6.14M

Market cap28.86M

RS 3m (vs SPY)+1884.00%

RS 6m (vs SPY)+2501.88%

RS line new highNo

Trend template6/8

Technical rank63.6

1 week-23.42%

1 month-39.02%

3 months+1740.84%

6 months+2194.23%

1 year+1107.87%

YTD+2854.31%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional1.89%

Ent. value28.86M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryDrug Manufacturers - Specialty & Generic

ExchangeNasdaq

Shares out540.84K

Employees6

ListedTue, Mar 15, 2022

Free float2.18M

Float %90.7%

Short interest75.81K

Days to cover0.1d

Short volume31.8%

Squeeze score7 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank63.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance58.45

Support12.16

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in AKAN

All disclosures →

No recent disclosed trades by Congress in AKAN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AKAN

No recent insider (Form 4) filings in AKAN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in AKAN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.